Vicarious Surgical Stock Analysis

RBOT Stock  USD 0.27  0.01  2.54%   
Vicarious Surgical is undervalued with Real Value of 1.83 and Target Price of 6.5. The main objective of Vicarious Surgical stock analysis is to determine its intrinsic value, which is an estimate of what Vicarious Surgical is worth, separate from its market price. There are two main types of Vicarious Surgical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Vicarious Surgical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Vicarious Surgical's stock to identify patterns and trends that may indicate its future price movements.
The Vicarious Surgical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Vicarious Surgical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Vicarious Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Vicarious Surgical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vicarious Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vicarious Stock please use our How to Invest in Vicarious Surgical guide.

Vicarious Stock Analysis Notes

About 32.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Vicarious Surgical recorded a loss per share of 0.49. The entity had not issued any dividends in recent years. Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Vicarious Surgical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 153 people. To find out more about Vicarious Surgical contact David Chu at 617 868 1700 or learn more at https://www.vicarioussurgical.com.

Vicarious Surgical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vicarious Surgical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vicarious Surgical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vicarious Surgical generated a negative expected return over the last 90 days
Vicarious Surgical has high historical volatility and very poor performance
Vicarious Surgical has some characteristics of a very speculative penny stock
Vicarious Surgical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (71.07 M) with profit before overhead, payroll, taxes, and interest of 0.
Vicarious Surgical currently holds about 126.8 M in cash with (62.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 32.0% of the company outstanding shares are owned by corporate insiders
Latest headline from businesswire.com: Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024

Vicarious Surgical Upcoming and Recent Events

Earnings reports are used by Vicarious Surgical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vicarious Surgical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of February 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
12th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Vicarious Largest EPS Surprises

Earnings surprises can significantly impact Vicarious Surgical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-07-27
2023-06-30-0.14-0.120.0214 
2022-05-09
2022-03-31-0.13-0.15-0.0215 
2021-11-08
2021-09-30-0.06-0.09-0.0350 
View All Earnings Estimates

Vicarious Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Vicarious Surgical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vicarious Surgical backward and forwards among themselves. Vicarious Surgical's institutional investor refers to the entity that pools money to purchase Vicarious Surgical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Renaissance Technologies Corp2023-12-31
685.8 K
Northern Trust Corp2023-12-31
587.2 K
Anglepoint Asset Management Ltd2023-12-31
534.9 K
Rothschild Investment Corp2023-09-30
330.6 K
Morgan Stanley - Brokerage Accounts2023-12-31
299.5 K
Charles Schwab Investment Management Inc2023-12-31
260.7 K
Bridgeway Capital Management, Llc2023-12-31
225 K
Bank Of New York Mellon Corp2023-12-31
189 K
Millennium Management Llc2023-12-31
171.7 K
Vk Services Llc2023-12-31
29 M
My.alpha Management Hk Advisors Ltd2023-12-31
7.4 M
Note, although Vicarious Surgical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vicarious Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.84 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vicarious Surgical's market, we take the total number of its shares issued and multiply it by Vicarious Surgical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Vicarious Profitablity

Vicarious Surgical's profitability indicators refer to fundamental financial ratios that showcase Vicarious Surgical's ability to generate income relative to its revenue or operating costs. If, let's say, Vicarious Surgical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Vicarious Surgical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Vicarious Surgical's profitability requires more research than a typical breakdown of Vicarious Surgical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.59)(0.56)
Return On Capital Employed(0.72)(0.75)
Return On Assets(0.59)(0.56)
Return On Equity(0.73)(0.69)

Management Efficiency

Vicarious Surgical has return on total asset (ROA) of (0.3841) % which means that it has lost $0.3841 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6801) %, meaning that it created substantial loss on money invested by shareholders. Vicarious Surgical's management efficiency ratios could be used to measure how well Vicarious Surgical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.56 in 2024. Return On Capital Employed is likely to drop to -0.75 in 2024. At this time, Vicarious Surgical's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 2.2 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.1 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 0.67  1.32 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 0.67  1.32 
Enterprise Value Over EBITDA(0.20)(0.21)
Price Book Value Ratio 0.55  0.52 
Enterprise Value Multiple(0.20)(0.21)
Price Fair Value 0.55  0.52 
Enterprise Value15.6 M14.8 M
The analysis of Vicarious Surgical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Vicarious Surgical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Vicarious Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.194

Technical Drivers

As of the 25th of April, Vicarious Surgical has the Variance of 96.56, coefficient of variation of (2,679), and Risk Adjusted Performance of (0.01). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vicarious Surgical, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down and interpolate data for thirteen technical drivers for Vicarious Surgical, which can be compared to its competition. Please validate Vicarious Surgical mean deviation and maximum drawdown to decide if Vicarious Surgical is priced more or less accurately, providing market reflects its prevalent price of 0.2729 per share. As Vicarious Surgical appears to be a penny stock we also recommend to double-check its jensen alpha numbers.

Vicarious Surgical Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Vicarious Surgical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Vicarious Surgical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Vicarious Surgical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vicarious Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vicarious Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vicarious Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vicarious Surgical Predictive Daily Indicators

Vicarious Surgical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vicarious Surgical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vicarious Surgical Forecast Models

Vicarious Surgical's time-series forecasting models are one of many Vicarious Surgical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vicarious Surgical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Vicarious Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vicarious Surgical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vicarious shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vicarious Surgical. By using and applying Vicarious Stock analysis, traders can create a robust methodology for identifying Vicarious entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.00  0.00 
Operating Profit Margin 0.00  0.00 
Net Profit Margin 0.00  0.00 
Gross Profit Margin 0.00  0.00 

Current Vicarious Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vicarious analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vicarious analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
6.5Buy4Odds
Vicarious Surgical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vicarious analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vicarious stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vicarious Surgical, talking to its executives and customers, or listening to Vicarious conference calls.
Vicarious Analyst Advice Details

Vicarious Stock Analysis Indicators

Vicarious Surgical stock analysis indicators help investors evaluate how Vicarious Surgical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vicarious Surgical shares will generate the highest return on investment. By understating and applying Vicarious Surgical stock analysis, traders can identify Vicarious Surgical position entry and exit signals to maximize returns.
Begin Period Cash Flow116.2 M
Total Stockholder Equity98 M
Capital Lease Obligations14.8 M
Total Liab21.9 M
Property Plant And Equipment Net17.9 M
Cash And Short Term Investments98.2 M
Net Invested Capital98 M
Cash52.8 M
50 Day M A0.3379
Net Interest Income4.2 M
Total Current Liabilities7.3 M
Investments-51.8 M
Interest Expense25 K
Stock Based Compensation13.3 M
Common Stock Shares Outstanding146 M
Free Cash Flow-64 M
Other Current Assets2.8 M
Accounts Payable1.3 M
Net Debt-38 M
Depreciation1.9 M
Other Operating Expenses80.7 M
Non Current Assets Total18.9 M
Liabilities And Stockholders Equity119.9 M
Non Currrent Assets Other114 K
When determining whether Vicarious Surgical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Vicarious Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vicarious Surgical Stock. Highlighted below are key reports to facilitate an investment decision about Vicarious Surgical Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vicarious Surgical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Vicarious Stock please use our How to Invest in Vicarious Surgical guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Vicarious Stock analysis

When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Vicarious Surgical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vicarious Surgical. If investors know Vicarious will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vicarious Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.49)
Return On Assets
(0.38)
Return On Equity
(0.68)
The market value of Vicarious Surgical is measured differently than its book value, which is the value of Vicarious that is recorded on the company's balance sheet. Investors also form their own opinion of Vicarious Surgical's value that differs from its market value or its book value, called intrinsic value, which is Vicarious Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vicarious Surgical's market value can be influenced by many factors that don't directly affect Vicarious Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vicarious Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vicarious Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vicarious Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.